tafenoquine has been researched along with Hemolysis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ager, AL; Bartlett, MS; Croft, SL; Khan, IA; McChesney, JD; Nanayakkara, NP; Walker, LA; Yardley, V | 1 |
| Chu, CS; Freedman, DO | 1 |
| Fernando, D; Rajapakse, S; Rodrigo, C | 1 |
2 review(s) available for tafenoquine and Hemolysis
| Article | Year |
|---|---|
Tafenoquine and G6PD: a primer for clinicians.
Topics: Aminoquinolines; Antimalarials; Contraindications, Drug; Dose-Response Relationship, Drug; Glucosephosphate Dehydrogenase Deficiency; Hemolysis; Humans; Malaria; Randomized Controlled Trials as Topic; Recurrence | 2019 |
Primaquine in vivax malaria: an update and review on management issues.
Topics: Aminoquinolines; Antimalarials; Artemisinins; Chloroquine; Clinical Trials as Topic; Drug Resistance; Glycogen Storage Disease Type I; Hemolysis; Humans; Malaria, Vivax; Plasmodium vivax; Primaquine | 2011 |
1 other study(ies) available for tafenoquine and Hemolysis
| Article | Year |
|---|---|
Antiparasitic activities and toxicities of individual enantiomers of the 8-aminoquinoline 8-[(4-amino-1-methylbutyl)amino]-6-methoxy-4-methyl-5-[3,4-dichlorophenoxy]quinoline succinate.
Topics: Aminoquinolines; Animals; Antifungal Agents; Antiprotozoal Agents; Dogs; Female; Hemolysis; Humans; Leishmania donovani; Leishmaniasis, Visceral; Malaria; Male; Methemoglobinemia; Mice; Mice, Inbred BALB C; Plasmodium berghei; Pneumocystis carinii; Pneumonia, Pneumocystis; Stereoisomerism; Structure-Activity Relationship | 2008 |